lifestyle.forkstofeet.com

Category: Globe Newswire

Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl

September 6, 2025
Beeline Eliminates $7 Million in Debt, Positioned for Cash Flow Positive Operations by Q1 2026

September 6, 2025
Forvis Mazars details strong growth, strategic investments in 2025 Integrated Report

September 6, 2025
Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™

September 6, 2025
Opus Genetics Doses First Patient in Pivotal LYNX-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions

September 6, 2025
Cancer Focus Fund Appoints Distinguished Industry Experts David R. Epstein and Michael Margolis as Advisors to Its Investment Committee

September 6, 2025
IO Biotech Announces Participation in Upcoming Investor Conferences

September 6, 2025
Five students impacted by ALS receive the 2025 ALS Canada Kevin Daly Bursary

September 6, 2025
SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025

September 6, 2025
PyroGenesis’ Latest Fumed Silica Test Results Post 3X Increase in Material Surface Area

September 6, 2025